OPK - OPKO Health, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.9600
+0.0400 (+2.08%)
At close: 4:00PM EDT

1.9400 -0.02 (-1.02%)
After hours: 7:04PM EDT

Stock chart is not supported by your current browser
Trade prices are not sourced from all markets
Previous Close1.9200
Open1.9500
Bid1.9400 x 1000
Ask1.9400 x 2200
Day's Range1.9200 - 1.9700
52 Week Range1.9000 - 6.4000
Volume2,474,780
Avg. Volume5,046,460
Market Cap1.207B
Beta (3Y Monthly)1.53
PE Ratio (TTM)N/A
EPS (TTM)-0.3350
Earnings DateAug 5, 2019 - Aug 9, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.00
  • GuruFocus.com3 days ago

    Weekly CEO Buys Highlight

    Details the CEO buys this past week for the following companies: Intrexon, Newmark Group, Continental Resources, Qurate Retail and OPKO Health

  • Markit4 days ago

    See what the IHS Markit Score report has to say about OPKO Health Inc.

    OPKO Health Inc NASDAQ/NGS:OPKView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate and increasing Bearish sentimentShort interest | NegativeShort interest is moderately high for OPK with between 10 and 15% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on May 9. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding OPK are favorable, with net inflows of $2.97 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • GlobeNewswire8 days ago

    Aerobic Vaginitis (AV) Testing Now Available At BioReference Laboratories

    BioReference Laboratories, Inc., an OPKO Health company, along with its specialty women’s health division, GenPath, today announces the launch of new testing for aerobic vaginitis (AV). AV is a vaginal infection caused by the overgrowth of aerobic bacteria that triggers an inflammatory response.

  • Benzinga9 days ago

    Why $2.7M In Opko Put Buying May Not Be As Bearish As It Seems

    Opko Health Inc. (NASDAQ: OPKO) shares are down 35 percent year-to-date, and the company’s first-quarter earnings report suggests management still hasn’t found a way to stop the company’s revenue declines. It can sometimes be difficult to determine if a large option trade represents a trader’s true sentiment toward the underlying stock, but there are clues to watch for.

  • Thomson Reuters StreetEvents11 days ago

    Edited Transcript of OPK earnings conference call or presentation 7-May-19 8:30pm GMT

    Q1 2019 OPKO Health Inc Earnings Call

  • Benzinga12 days ago

    Notable Insider Buys This Past Week: Annaly Capital, MGM and More

    Conventional wisdom says that insiders and 10 percent owners really only buy shares of a company for one reason -- they believe the stock price will rise and they want to profit from it. MGM Resorts International (NYSE: MGM) saw a director last week acquire 80,000 shares of this Las Vegas-based hospitality and entertainment company. At share prices ranging from $25.07 to $25.69, the transaction totaled more than $20.32 million.

  • Do Options Traders Know Something About OPKO Health (OPK) Stock We Don't?
    Zacks15 days ago

    Do Options Traders Know Something About OPKO Health (OPK) Stock We Don't?

    Investors need to pay close attention to OPKO Health (OPK) stock based on the movements in the options market lately.

  • OPKO Health (OPK) Reports Loss in Q1, Misses Revenue Estimates
    Zacks16 days ago

    OPKO Health (OPK) Reports Loss in Q1, Misses Revenue Estimates

    Lower revenues, weak performing product segment and contraction in gross margin impact OPKO Health's (OPK) Q1 results.

  • Benzinga16 days ago

    The Daily Biotech Pulse: Novartis Goes Shopping, Mixed Trial Results For Provention Bio, 4 Stocks To Debut

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 8) Alcon AG (NYSE: ALC ) BioSig Technologies Inc (NASDAQ: ...

  • Why Opko Health Stock Sank Today
    Motley Fool16 days ago

    Why Opko Health Stock Sank Today

    Disappointing Q1 results weighed on the healthcare stock.

  • Benzinga17 days ago

    The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on May 7) Axsome Therapeutics Inc (NASDAQ: AXSM ) BioSig Technologies ...

  • Bet on Top Stocks With Rising P/E to Enjoy Solid Gains
    Zacks17 days ago

    Bet on Top Stocks With Rising P/E to Enjoy Solid Gains

    Want to try an out-of-the-box approach? Tap five stocks with increasing P/E ratios.

  • Opko Health (OPK) Q1 2019 Earnings Call Transcript
    Motley Fool17 days ago

    Opko Health (OPK) Q1 2019 Earnings Call Transcript

    OPK earnings call for the period ending March 31, 2019.

  • Associated Press17 days ago

    OPKO Health: 1Q Earnings Snapshot

    On a per-share basis, the Miami-based company said it had a loss of 14 cents. The holding company with investments in pharmaceutical and diagnostics companies posted revenue of $222.5 million in the period. ...

  • GlobeNewswire17 days ago

    OPKO Health Reports 2019 First Quarter Business Highlights and Financial Results

    MIAMI, May 07, 2019 -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2019. Business Highlights.

  • GlobeNewswire22 days ago

    BioReference Laboratories to Present at ACOG 2019, Demonstrating Commitment to the Research of Hereditary Conditions

    BioReference Laboratories, Inc., an OPKO Health Company, along with its women’s health division GenPath, today announced the presentation of new research from its prenatal and hereditary cancer assessment programs at the 2019 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting in Nashville, Tennessee from May 3-6. The poster presentations demonstrate the company’s commitment to advancing the research of hereditary conditions.

  • How Does OPKO Health, Inc. (NASDAQ:OPK) Affect Your Portfolio Volatility?
    Simply Wall St.23 days ago

    How Does OPKO Health, Inc. (NASDAQ:OPK) Affect Your Portfolio Volatility?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Anyone researching OPKO Health, Inc. (NASDAQ:OPK) might want to consider the historical volatility of...

  • Is Opko Health Inc. (OPK) A Good Stock To Buy?
    Insider Monkey23 days ago

    Is Opko Health Inc. (OPK) A Good Stock To Buy?

    With the fourth-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the first quarter. One of these stocks was Opko Health Inc. (NASDAQ:OPK). Opko Health Inc. (NASDAQ:OPK) has seen […]

  • GlobeNewswire25 days ago

    OPKO Health to Report First Quarter 2019 Financial Results on May 7, 2019

    MIAMI, April 30, 2019 -- OPKO Health, Inc. (NASDAQ: OPK) plans to report its operating and financial results for the three months ended March 31, 2019, as well as provide.

  • GuruFocus.comlast month

    Stocks That Fell to 3-Year Lows in the Week of April 19

    Gilead Sciences Inc., CVS Health Corp, Macerich Co. and OPKO Health Inc. have declined to their respective three-year lows

  • GlobeNewswirelast month

    BioReference Laboratories Recognized by Forbes as Best Large Employer of 2019

    BioReference Laboratories, Inc., an OPKO Health Company (OPK), is pleased to announce it has been recognized by Forbes as one of America’s Best Large Employers of 2019. This list includes 500 large companies, and BioReference is one of only 15 companies in the Health Care Equipment and Services category to be selected for this designation. BioReference provides comprehensive laboratory testing to physicians, clinics, hospitals, employers, government entities, correctional institutions and medical groups.